Dr Suchita Shrestha
Contact information
Suchita Shrestha
Head of the Clinical Trials Unit, OUCRU Nepal
Dr Suchita Shrestha brings over nine years of extensive experience in the management and coordination of clinical trials, with a focus on infectious diseases, including typhoid, influenza, COVID-19, community-acquired pneumonia (CAP), and respiratory syncytial virus (RSV).
With extensive experience in overseeing complex research studies, Dr Shrestha plays a pivotal role in ensuring compliance with regulatory requirements, adherence to ethical standards, and the generation of high-quality clinical data. Her expertise includes study planning, implementation, coordination, and cross-functional team leadership.
Through her work, Dr Shrestha contributes to the advancement of high-quality clinical research and the strengthening of the organization’s capacity to conduct scientifically rigorous and globally relevant trials.
Recent publications
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
Journal article
Schilling WHK. et al, (2024), PLOS Medicine, 21, e1004428 - e1004428
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2023), The Lancet, 401, 1499 - 1507
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 143 - 151
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
Journal article
Shakya M. et al, (2021), The Lancet Global Health, 9, e1561 - e1568
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby PW. et al, (2021)